Eledon Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELDN and other ETFs, options, and stocks.About ELDN
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm’s compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential.
ELDN Key Statistics
Stock Snapshot
Eledon Pharmaceuticals(ELDN) stock is priced at $2.19, giving the company a market capitalization of 161.43M. It carries a P/E multiple of -1.78.
As of 2026-01-24, Eledon Pharmaceuticals(ELDN) stock has fluctuated between $2.10 and $2.29. The current price stands at $2.19, placing the stock +4.3% above today's low and -4.4% off the high.
The Eledon Pharmaceuticals(ELDN)'s current trading volume is 690.02K, compared to an average daily volume of 818.26K.
During the past year, Eledon Pharmaceuticals(ELDN) stock moved between $1.35 at its lowest and $4.97 at its peak.
During the past year, Eledon Pharmaceuticals(ELDN) stock moved between $1.35 at its lowest and $4.97 at its peak.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.